HPS Pharmacies wish to advise that Viatris is experiencing a supply interruption for Nitrostat® sublingual tablets as follows:
Nitrostat® 300 mcg
Glyceryl trinitrate (nitroglycerin) sublingual tablets
This product was approved for supply under Section 19A of the Therapeutic Goods Act 1989 following the discontinuation of the Australian registered brands. Supply under this approval has now ceased due to the introduction of Australian-registered Nitrostat® sublingual tablets.
Supplies of Nitrostat® 300mcg tablets (ARTG 438870) are expected to be available within the next 3-4 weeks.
Supplies of Nitrolingual® Pumpspray (glyceryl trinitrate 400mcg/metered dose) are not affected by this notice.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Viatris on 1800 274 276, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates